On CNBC’s “Mad Money Lightning Round,” Jim Cramer said Nuvation Bio Inc. (NYSE:NUVB) is a “pure spec.”
Nuvation Bio, on Aug. 20, was granted the FDA Fast Track Designation for safusidenib for the treatment of IDH1-mutant glioma
When asked about IREN Limited (NASDAQ:IREN), Cramer said, “If you’re going to do neoclouds, the only one I like is CoreWeave (NASDAQ:CRWV).”
On Sept. 2, BTIG analyst Gregory Lewis reiterated a Buy rating on IREN and maintained a price target of $80.
Cramer said he doesn’t know about Seneca Foods Corporation (NASDAQ:SENEA).
On the earnings front, Seneca Foods posted mixed results for the first quarter on Aug. 6.
“I think people recognize it is a lot harder to build a nuclear power plant,” Cramer said when asked about NuScale Power Corporation (NYSE:SMR). “It’s just really, really hard. That’s why we own GE Vernova (NYSE:GEV) for the Trust because at least it’s got some nuclear, and I don’t feel like the thing’s going to get too out of control.”
NuScale reported second-quarter losses of 13 cents per share on Aug. 5, meeting the consensus estimate, according to Benzinga Pro data. Quarterly revenue of $75,000 missed the analyst consensus estimate of $8.91 million.
Cramer likes cloud-based content management company Box, Inc. (NYSE:BOX), adding that the stock is finally breaking out after multiple years.
The Redwood City, California-based company posted second-quarter earnings of 40 cents per share on Aug. 25, meeting the analyst consensus estimate. Its reported quarterly sales were $321.100 million, beating the analyst consensus estimate of $319.331 million.
Price Action
- Seneca Foods shares fell 1.5% to settle at $204.28 on Thursday.
- Nuscale Power shares rose 2% to close at $9.75 during the session.
- IREN gained 5.2% to settle at $41.65 on Thursday.
- Box shares gained 4% to close at $35.96.
- Nuvation Bio shares declined 2.3% to settle at $6.77.
Photo via Shutterstock